Four de novo mutations in the GABRA1 variants were identified in six unrelated cases, including two with epilepsy with febrile seizures plus (EFS +), three with developmental and epileptic encephalopathy (DEE), and one with epilepsy with generalized tonic-clonic seizures alone (GTCA). This evidence concerns the gene GABRA1 and epilepsy.